11C-methionine PET imaging characteristics in children with diffuse intrinsic pontine gliomas and relationship to survival and H3 K27M mutation status
- PMID: 36697961
- DOI: 10.1007/s00259-022-06105-z
11C-methionine PET imaging characteristics in children with diffuse intrinsic pontine gliomas and relationship to survival and H3 K27M mutation status
Abstract
Purpose: This study aimed to describe 11C-methionine (11C-MET) PET imaging characteristics in patients with paediatric diffuse intrinsic pontine glioma (DIPG) and correlate them with survival and H3 K27M mutation status.
Methods: We retrospectively analysed 98 children newly diagnosed with DIPG who underwent 11C-MET PET. PET imaging characteristics evaluated included uptake intensity, uniformity, metabolic tumour volume (MTV), and total lesion methionine uptake (TLMU). The maximum, mean, and peak of the tumour-to-background ratio (TBR), calculated as the corresponding standardised uptake values (SUV) divided by the mean reference value, were also recorded. The associations between the PET imaging characteristics and clinical outcomes in terms of progression-free survival (PFS) and overall survival (OS) and H3 K27M mutation status were assessed, respectively.
Results: In univariate analysis, imaging characteristics significantly associated with shorter PFS and OS included a higher uniformity grade, higher TBRs, larger MTV, and higher TLMU. In multivariate analysis, larger MTV at diagnosis, shorter symptom duration, and no treatment were significantly correlated with shorter PFS and OS. The PET imaging features were not correlated with H3 K27M mutation status.
Conclusion: Although several imaging features were significantly associated with PFS and OS, only MTV, indicating the size of the active tumour, was identified as a strong independent prognostic factor.
Keywords: 11C-methionine PET; DIPG; Diffuse midline glioma; Paediatric; Prognostic factor.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG.Acta Neuropathol Commun. 2020 Apr 23;8(1):57. doi: 10.1186/s40478-020-00930-9. Acta Neuropathol Commun. 2020. PMID: 32326973 Free PMC article.
-
Evaluation of 11C-Methionine PET and Anatomic MRI Associations in Diffuse Intrinsic Pontine Glioma.J Nucl Med. 2019 Mar;60(3):312-319. doi: 10.2967/jnumed.118.212514. Epub 2018 Aug 2. J Nucl Med. 2019. PMID: 30072503 Free PMC article.
-
H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions.Neuro Oncol. 2024 May 3;26(Supplement_2):S110-S124. doi: 10.1093/neuonc/noad220. Neuro Oncol. 2024. PMID: 38102230 Free PMC article. Review.
-
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1155-1164. doi: 10.1007/s00259-017-3618-3. Epub 2017 Jan 21. Eur J Nucl Med Mol Imaging. 2017. PMID: 28110346
-
Epigenetic reprogramming and chromatin accessibility in pediatric diffuse intrinsic pontine gliomas: a neural developmental disease.Neuro Oncol. 2020 Feb 20;22(2):195-206. doi: 10.1093/neuonc/noz218. Neuro Oncol. 2020. PMID: 32078691 Free PMC article. Review.
Cited by
-
Advanced imaging techniques and non-invasive biomarkers in pediatric brain tumors: state of the art.Neuroradiology. 2024 Dec;66(12):2093-2116. doi: 10.1007/s00234-024-03476-y. Epub 2024 Oct 9. Neuroradiology. 2024. PMID: 39382639 Review.
-
Distribution of glutamate and glutamine in tumor microenvironments of brain metastasis: Insights from biochemical analysis and molecular imaging.iScience. 2025 Aug 14;28(9):113371. doi: 10.1016/j.isci.2025.113371. eCollection 2025 Sep 19. iScience. 2025. PMID: 40933642 Free PMC article.
-
Applications of artificial intelligence and advanced imaging in pediatric diffuse midline glioma.Neuro Oncol. 2025 Jul 30;27(6):1419-1433. doi: 10.1093/neuonc/noaf058. Neuro Oncol. 2025. PMID: 40037540 Free PMC article. Review.
-
H3 K27-altered diffuse midline glioma in adults arising from atypical regions: Two case reports and literature review.Radiol Case Rep. 2023 Nov 3;19(1):200-206. doi: 10.1016/j.radcr.2023.10.031. eCollection 2024 Jan. Radiol Case Rep. 2023. PMID: 38028289 Free PMC article.
-
From Seeing to Healing: The Clinical Potential of Radiotracers in Pediatric Neuro-Oncology.Cancers (Basel). 2025 Jun 7;17(12):1905. doi: 10.3390/cancers17121905. Cancers (Basel). 2025. PMID: 40563556 Free PMC article. Review.
References
-
- Jansen MH, Veldhuijzen van Zanten SE, Sanchez Aliaga E, Heymans MW, Warmuth-Metz M, Hargrave D, et al. Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro Oncol. 2015;17:160–6. https://doi.org/10.1093/neuonc/nou104 . - DOI - PubMed
-
- Wagner S, Warmuth-Metz M, Emser A, Gnekow AK, Strater R, Rutkowski S, et al. Treatment options in childhood pontine gliomas. J Neurooncol. 2006;79:281–7. https://doi.org/10.1007/s11060-006-9133-1 . - DOI - PubMed
-
- Gokce-Samar Z, Beuriat PA, Faure-Conter C, Carrie C, Chabaud S, Claude L, et al. Pre-radiation chemotherapy improves survival in pediatric diffuse intrinsic pontine gliomas. Childs Nerv Syst. 2016;32:1415–23. https://doi.org/10.1007/s00381-016-3153-8 . - DOI - PubMed
-
- Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol. 2006;7:241–8. https://doi.org/10.1016/S1470-2045(06)70615-5 . - DOI - PubMed
-
- Jansen MH, van Vuurden DG, Vandertop WP, Kaspers GJ. Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology. Cancer Treat Rev. 2012;38:27–35. https://doi.org/10.1016/j.ctrv.2011.06.007 . - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous